Exclusion criteria
Last imported at : April 14, 2021, 2:05 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
1. Those who are allergic to any component of the vaccine, and those who have history of severe allergic reactions to the vaccine, such as acute allergic reactions, urticaria, skin eczema, dyspnea, angioedema or abdominal pain,
2. Those with fever or those who suffer from acute diseases or severe chronic diseases in the acute stage of onset,
3. Pregnant women, lactating women, or having a pregnancy plan within 3 months,
4. Patients with a history or family history of convulsions, epilepsy, encephalopathy or mental illness, Patients with uncontrolled epilepsy and other progressive neurological diseases, Patients with a history of Guillain-Barré syndrome,
5. Those who have been diagnosed with congenital or acquired immunodeficiency HIV infected lymphoma leukemia or other autoimmune diseases,
6. Those who have severe respiratory diseases, severe cardiovascular diseases, liver and kidney diseases and malignant tumors,
7. A history of COVID-19 infection,
8. Patients who take medicine affecting the immune function, such as immunosuppressant agents or immunopotentiators or glucocorticoids (>=10mg prednisone or other equivalent glucocorticoids) within one month before enrollment,
9. Those who are considered unsuitable for vaccination by clinicians.
|
Arms
Last imported at : April 14, 2021, 2:05 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
[{"arm_notes": "Vaccinated in the morning;2", "treatment_id": 643, "treatment_name": "Inactivated covid-19 vaccine", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Vaccinated in the afternoon;2", "treatment_id": 643, "treatment_name": "Inactivated covid-19 vaccine", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]
|